NCT00034606View on ClinicalTrials.gov

Comparing 3 Schedules of Alimta Plus Gemzar

PHASE2CompletedINTERVENTIONAL

Timeline

Start Date

Not specified

Conditions

Carcinoma, Non-Small-Cell LungLung NeoplasmsNeoplasms

Interventions

DRUG

Pemetrexed (Alimta) in combination with gemcitabine (Gemzar)

Trial Locations (1)

Unknown

Rochester

All Listed Sponsors

lead

Eli Lilly and Company

INDUSTRY

NCT00034606 - Comparing 3 Schedules of Alimta Plus Gemzar | Biotech Hunter | Biotech Hunter